Sep 2026
Abstract A137: Chemotherapy utilization and outcomes in patients with metastatic pancreatic adenocarcinoma
In a large cohort of patients with de novo mPDAC, more than half of patients were untreated or unable to tolerate CTx, possibly related to older age and worse PS, and this findings highlight a significant need for improved treatment options for mPDAC.
Shubham Pant, P. Pradhan, Yue-Xi Wang et al.
· Cancer Research · 0 citations